MedTrace Logo

Innate Immunity and the Allergic Response

NCT01494948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine if a certain cell type (the CD49d+ neutrophil) is associated with the presence or development of allergic disease.

Conditions

  • Nasal Allergies

Interventions

OTHER

allergen challenge

nasal challenges with antigen to which they are sensitive to

Sponsors & Collaborators

Principal Investigators

  • Mitchell Grayson, MD · Medical College of Wisconsin

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01494948 on ClinicalTrials.gov